Molly A. Taylor

2.2k citations
30 papers · 1.7k indexed · h-index 18
Topics
MicroRNA in disease regulation (7 papers)Cancer Immunotherapy and Biomarkers (6 papers)Cancer Cells and Metastasis (5 papers)

In The Last Decade

Molly A. Taylor

30 papers receiving 1.6k citations

Peers

Molly A. Taylor
Comparison fields: 5 of 87
  • Molecular Biology 970
  • Oncology 624
  • Cancer Research 510
  • Immunology 432
  • Pulmonary and Respiratory Medicine 146
Replace Jie Dai with:
Jie Dai China
P Wülfing Germany
Marcus Bosenberg United States
Ethan V. Abel United States
Eiji Toyoda Japan
Kazuhiro Kami Japan
Roderik M. Kortlever United States
Satoru Shinriki Japan
Brian C. Grabiner United States
Molly A. Taylor relative to Jie Dai China Jie Dai's profile →
Citations per field
00.5×4.3×
Jie Dai · 1×
Citations per year

Countries citing papers authored by Molly A. Taylor

Since Specialization
Citations

This map shows the geographic impact of Molly A. Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Molly A. Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molly A. Taylor more than expected).

Fields of papers citing papers by Molly A. Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Molly A. Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Molly A. Taylor. The network helps show where Molly A. Taylor may publish in the future.

Co-authorship network of co-authors of Molly A. Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Molly A. Taylor. A scholar is included among the top collaborators of Molly A. Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Molly A. Taylor. Molly A. Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 14
3 70
4 40
5 1
6 71
7 28
8 25
9 70
10 2
11 9
12 52
13 251
14 82
15 99
16 144
17 17
18 195
19 254
20 5

About Molly A. Taylor

Molly A. Taylor is a scholar working on Cancer Research, Oncology and Immunology, having authored 30 papers that have together received 1.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Cells and Metastasis (5 papers). The work is most often cited by research in Cancer Research (510 citations), Oncology (624 citations) and Immunology (432 citations). Molly A. Taylor has collaborated with scholars based in United States, United Kingdom and Singapore. Frequent co-authors include William P. Schiemann, Jenny G. Parvani, Khalid Sossey‐Alaoui, Michael K. Wendt, Barbara J. Schiemann, Cheryl L. Thompson, David Danielpour, Rebecca L. O’Brien, Willi K. Born and Christina L. Roark. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Immunology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026